ProCE Banner Activity

Antibody–Drug Conjugates in EGFR-Mutated NSCLC

Slideset

Downloadable slides from a live satellite symposium on the use of HER3-targeted ADCs in the management of EGFR-mutated NSCLC.

Released: September 16, 2024

Expiration: September 15, 2025

Share

Faculty

Helena Yu

Helena Yu, MD

Associate Attending
Research Director
Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc.